Pentraxin 3 is a marker of early joint inflammation in patients with juvenile idiopathic arthritis

Keyphrases

• Systemic Juvenile Idiopathic Arthritis (sJIA) 100%
• Joint Inflammation 100%
• Pentraxin 3 (PTX3) 100%
• Synovial Fluid 68%
• Three-level 56%
• Synovial Cells 18%
• Disease Course 12%
• Clinical Characteristics 12%
• In Vitro Activation 12%
• Arthritis Patients 12%
• Inflammation 6%
• Disease Severity 6%
• Clinical Features 6%
• Body Tissues 6%
• Tumor Necrosis Factor-α 6%
• C-reactive Protein 6%
• Disease Therapy 6%
• Arthritis 6%
• Single Center 6%
• Synoviocytes 6%
• Acute Phase Proteins 6%
• Disease-modifying Antirheumatic Drugs (DMARDs) 6%
• Joint Swelling 6%

Immunology and Microbiology

• Arthritis 100%
• Synovial Fluid 100%
• Juvenile Idiopathic Arthritis 100%
• Secretion (Process) 27%
• Cell Line 27%
• C-Reactive Protein 9%
• Synoviocyte 9%
• Acute Phase Protein 9%
• Disease-Modifying Antirheumatic Drug 9%